| Title |
Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2012
|
| DOI | 10.1002/14651858.cd009665 |
| Pubmed ID | |
| Authors |
Christopher J Derry, Sheena Derry, R Andrew Moore |
| Abstract |
Migraine is a highly disabling condition for the individual and also has wide-reaching implications for society, healthcare services, and the economy. Sumatriptan is an abortive medication for migraine attacks, belonging to the triptan family. Subcutaneous administration may be preferable to oral for individuals experiencing nausea and/or vomiting |
Twitter Demographics
The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 22% |
| Canada | 1 | 11% |
| India | 1 | 11% |
| France | 1 | 11% |
| United States | 1 | 11% |
| Unknown | 3 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 56% |
| Scientists | 3 | 33% |
| Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Colombia | 1 | <1% |
| United States | 1 | <1% |
| France | 1 | <1% |
| Unknown | 148 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 18% |
| Student > Bachelor | 15 | 10% |
| Researcher | 13 | 9% |
| Student > Doctoral Student | 12 | 8% |
| Other | 10 | 7% |
| Other | 25 | 16% |
| Unknown | 49 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 34% |
| Psychology | 13 | 9% |
| Nursing and Health Professions | 10 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Neuroscience | 4 | 3% |
| Other | 13 | 9% |
| Unknown | 52 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2022.
All research outputs
#3,361,141
of 23,305,591 outputs
Outputs from Cochrane database of systematic reviews
#6,068
of 12,448 outputs
Outputs of similar age
#29,015
of 253,217 outputs
Outputs of similar age from Cochrane database of systematic reviews
#77
of 217 outputs
Altmetric has tracked 23,305,591 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,448 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.8. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,217 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 217 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.